Culprit only versus multivessel coronary revascularization in patients presenting with acute ST elevation myocardial...

Area of Science:

• Cardiology
• Interventional Cardiology
• Acute Myocardial Infarction

Background:

• Current guidelines recommend percutaneous coronary intervention (PCI) for non-culprit lesions only in the infarct-related artery during acute myocardial infarction (AMI).
• Multivessel disease in AMI presents a complex interventional challenge regarding the management of non-culprit lesions.

Discussion:

• The optimal strategy for significant non-culprit lesions in multivessel AMI remains controversial.
• Individualized PCI decisions for non-infarct vessels should be guided by objective evidence of significant residual ischemia.
• Exceptions include patients with multivessel disease and hemodynamic compromise, where intervention may be more broadly indicated.

Key Insights:

• PCI of non-culprit lesions in multivessel AMI requires careful consideration beyond current guideline limitations.
• Objective assessment of residual ischemia is crucial for guiding intervention in non-infarct related vessels.
• A personalized approach may improve outcomes in selected AMI patients.

Outlook:

• Large, randomized clinical trials are necessary to definitively resolve the optimal interventional strategy.
• Future research should focus on identifying specific patient subgroups who benefit most from non-culprit lesion intervention.
• Evidence-based guidelines may evolve with further data from prospective studies.